Overview
Mickleson syndrome (also sometimes spelled Mickelson syndrome) is an extremely rare condition that was historically listed in medical databases but has since been marked as obsolete in the Orphanet classification system (ORPHA:2507). This means that the condition may have been reclassified, merged with another diagnosis, or determined to no longer represent a distinct clinical entity based on updated medical understanding. Very little published medical literature exists specifically about this syndrome, making it difficult to provide a comprehensive clinical description. Because this entry is considered obsolete, patients or families who were previously given this diagnosis should speak with a clinical geneticist to determine whether their condition now falls under a different, currently recognized diagnosis. Advances in genetic testing and clinical understanding frequently lead to the reclassification of rare syndromes. A genetics specialist can help clarify the correct current diagnosis, which is important for accessing appropriate care, treatment options, and support resources. If you or a family member has been told they have Mickleson syndrome, seeking an updated genetic evaluation is strongly recommended.
Treatments
No FDA-approved treatments are currently listed for OBSOLETE: Mickleson syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for OBSOLETE: Mickleson syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for OBSOLETE: Mickleson syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to OBSOLETE: Mickleson syndrome.
Community
No community posts yet. Be the first to share your experience with OBSOLETE: Mickleson syndrome.
Start the conversation →Latest news about OBSOLETE: Mickleson syndrome
No recent news articles for OBSOLETE: Mickleson syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.My diagnosis is listed as Mickleson syndrome, which is now considered obsolete. What does this mean for me?,Should I undergo updated genetic testing to get a more current diagnosis?,What type of genetic testing would you recommend, and what can it tell us?,Are there any currently recognized conditions that my symptoms might fit under?,How will getting an updated diagnosis affect my access to treatments or clinical trials?,Can you refer me to a genetic counselor to help me understand my results?,Are there any patient support groups that might be relevant to my symptoms?
Common questions about OBSOLETE: Mickleson syndrome
What is OBSOLETE: Mickleson syndrome?
Mickleson syndrome (also sometimes spelled Mickelson syndrome) is an extremely rare condition that was historically listed in medical databases but has since been marked as obsolete in the Orphanet classification system (ORPHA:2507). This means that the condition may have been reclassified, merged with another diagnosis, or determined to no longer represent a distinct clinical entity based on updated medical understanding. Very little published medical literature exists specifically about this syndrome, making it difficult to provide a comprehensive clinical description. Because this entry is